Teva Pharmaceutical Industries Ltd. ADR (TEVA) Social Stream
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TEVA PHARMACEUTICAL INDUSTRIES LTD.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-12-30 | 10 | $11 | $10 | $10.5 | $10.54 | -0.38% |
2022-02-07 | 11 | $11 | $10 | $10.5 | $10.54 | -0.38% |
2022-02-10 | 11 | $11 | $9 | $10.375 | $10.54 | -1.57% |
2022-03-25 | 12 | $11 | $9 | $10.444 | $10.54 | -0.91% |
2022-04-05 | 13 | $13 | $9 | $10.7 | $10.54 | 1.52% |
2022-04-28 | 12 | $13 | $10 | $10.777 | $10.54 | 2.25% |
2022-05-04 | 12 | $13 | $10 | $10.75 | $10.54 | 1.99% |
2022-05-16 | 11 | $13 | $7 | $10.125 | $10.54 | -3.94% |
2022-06-10 | 12 | $13 | $7 | $10.125 | $10.54 | -3.94% |
2022-06-14 | 11 | $13 | $7 | $10.125 | $10.54 | -3.94% |
2022-07-25 | 11 | $13 | $7 | $10.25 | $10.54 | -2.75% |
2022-07-28 | 11 | $13 | $8 | $10.428 | $10.54 | -1.06% |
2022-08-04 | 10 | $13 | $8 | $10.375 | $10.54 | -1.57% |
2022-09-17 | 10 | $13 | $8 | $10.75 | $10.54 | 1.99% |
2022-10-14 | 9 | $13 | $8 | $10.5 | $10.54 | -0.38% |
2022-11-03 | 10 | $13 | $8 | $10.5 | $10.54 | -0.38% |
2022-11-04 | 12 | $13 | $8 | $10.5 | $10.54 | -0.38% |
2022-11-08 | 13 | $13 | $8 | $10.444 | $10.54 | -0.91% |
2022-11-14 | 13 | $13 | $8 | $10.3 | $10.54 | -2.28% |
2022-11-23 | 13 | $13 | $7 | $10.2 | $10.54 | -3.23% |
2022-12-16 | 13 | $13 | $7 | $10.1 | $10.54 | -4.17% |
2023-01-09 | 13 | $13 | $7 | $10.3 | $10.54 | -2.28% |
2023-01-26 | 13 | $13 | $7 | $10.5 | $10.54 | -0.38% |
The Trend in the Analyst Price Target
Over the past 131 days, TEVA's average price target has gone down $0.25.
Over the past 50 weeks, TEVA's average upside potential has been 15.71%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-06-10 | 12 | 13 | 7 | 10.125 | 8.32 | 21.69% |
2022-08-05 | 10 | 13 | 8 | 10.750 | 10.69 | 0.56% |
2022-08-24 | 10 | 13 | 8 | 10.750 | 10.03 | 7.18% |
2022-11-08 | 13 | 13 | 8 | 10.444 | 9.08 | 15.02% |
2022-12-16 | 13 | 13 | 7 | 10.100 | 8.69 | 16.23% |
TEVA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 3 | 0 | 7 | 3 | 3 | 13 |
The Trend in the Broker Recommendations
TEVA's average broker recommendation rating worsened by 0.29 over the prior 28 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TEVA as an investment opportunity.
- TEVA has a greater average analyst price target than 334.99% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's upside potential (average analyst target price relative to current price) is higher than 434.19% of them.
- TEVA PHARMACEUTICAL INDUSTRIES LTD's number of analysts covering the stock is greater than 2429.77% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's variance in analysts' estimates is lower than -794.54% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TEVA PHARMACEUTICAL INDUSTRIES LTD are PRGO, MRTX, and ZTS.
View All Top Stocks by Price Target
Make investment decisions regarding TEVA using the data that counts. Try POWR Ratings for free.